Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis

被引：0
|
作者：
Tina Bhutani
John Koo
Jayme Heim
Neal Bhatia
Jacob Mathew
Thomas Ferro
J. Gabriel Vasquez
机构：
[1] University of California San Francisco Health,
[2] West Michigan Dermatology,undefined
[3] Therapeutics Clinical Research,undefined
[4] Sun Pharmaceutical Industries,undefined
[5] Inc.,undefined
来源：
Dermatology and Therapy | 2024年 / 14卷
关键词：
Psoriasis; Tildrakizumab; Work productivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1019 / 1025
页数：6
相关论文
共 50 条
  • [1] Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis
    Bhutani, Tina
    Koo, John
    Heim, Jayme
    Bhatia, Neal
    Mathew, Jacob
    Ferro, Thomas
    Vasquez, J. Gabriel
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (04) : 1019 - 1025
  • [2] PSORIASIS-RELATED WORK PRODUCTIVITY IMPROVEMENT FROM A PHASE 4 REAL-WORLD STUDY OF TILDRAKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Bhatia, N.
    Heim, J.
    Schenkel, B.
    Rozzo, S. J.
    Vasquez, J. G.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S346 - S347
  • [3] Safety of tildrakizumab in a Phase 4 real-world study in patients with moderate-to-severe plaque psoriasis
    Vasquez, J. Gabriel
    Bhatia, Neal
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB85 - AB85
  • [4] REAL-WORLD EFFECTIVENESS AND SAFETY IN A PHASE 4 STUDY OF TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Bhatia, N.
    Vasquez, J. G.
    Schenkel, B.
    Rozzo, S. J.
    Heim, J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S57 - S57
  • [5] Patients' quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis
    Heim, Jayme
    Vasquez, J. Gabriel
    Rozzo, Stephen J.
    Schenkel, Brad
    Bhatia, Neal
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB204 - AB204
  • [6] PSORIASIS-RELATED WORK PRODUCTIVITY IMPROVEMENT FROM A PHASE 4 REAL-WORLD STUDY INTERIM ANALYSIS OF TILDRAKIZUMAB
    Bhatia, N.
    Heim, J.
    Beute, P.
    Torres, M.
    Schenkel, B.
    Rozzo, S. J.
    Vasquez, J. G.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S390 - S391
  • [7] Patient satisfaction with tildrakizumab treatment in a Phase 4 real-world study of tildrakizumab in patients with moderate-to-severe psoriasis
    Bhatia, Neal
    Vasquez, J. Gabriel
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB72 - AB72
  • [8] Real-world effectiveness of tildrakizumab in a Phase 4 study in patients with moderate-to- severe plaque psoriasis
    Bhatia, Neal
    Vasquez, J. Gabriel
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB216 - AB216
  • [9] Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting
    Bhatia, Neal
    Heim, Jayme
    Vasquez, J. Gabriel
    Bhutani, Tina
    Schenkel, Brad
    Gogineni, Ranga
    Koo, John
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [10] A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis
    Gabrielle Becher
    Sophia Conner
    Jennifer A. Ingram
    Karen E. Stephen
    Alison C. McInnes
    Adrian H. Heald
    Paul A. Riley
    Mark Davies
    Arnau Domenech
    Ismail Kasujee
    [J]. Dermatology and Therapy, 2022, 12 : 2343 - 2354
12345